GL1X · GenesisL1 explorer

Research workbench

Crystal structure of rhogdi E155S, E157S mutant

Analyse Crystal structure of rhogdi E155S, E157S mutant in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2JHZ
Type
protein
Length
276 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Rho GDP-dissociation inhibitor 1
UniProt
P52565
Pockets
3 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BRho GDP-dissociation inhibitor 1protein1387% helix, 56% strandP52565

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13520.620.7946empty
21380.510.7921empty
3800.400.7815empty

Interfaces

1 interface between chains.

  • A–B · 579 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 2JHZ · Crystal structure of rhogdi E155S, E157S mutant · the same entry in another collection · chain A against A, TM-score 1.00
  • P52565 · AlphaFold monomer V2.0 prediction for rho GDP-dissociation inhibitor 1 (P52565) · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.